Amphastar Pharmaceuticals Inc (AMPH)
Depreciation & Amortization
$63.07M
TTM · Period ending: · USD
AMPH Depreciation & Amortization
Latest reported$63.07Mperiod ending
Latest reported$63.07Mperiod ending
AMPH TTM Depreciation & Amortization ($13.08M → $63.07M)
TTM Depreciation & Amortization
High-resolution chart · PNG
AMPH depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 63,068,000 | |
| 62,847,000 | |
| 61,562,000 | |
| 60,239,000 | |
| 60,543,000 | |
| 58,449,000 | |
| 57,205,000 | |
| 56,330,000 | |
| 55,468,000 | |
| 48,344,000 | |
| 41,777,000 | |
| 35,422,000 | |
| 29,176,000 | |
| 28,984,000 | |
| 28,383,000 | |
| 27,500,000 | |
| 26,685,000 | |
| 26,722,000 | |
| 26,752,000 | |
| 26,971,000 | |
| 27,131,000 | |
| 26,183,000 | |
| 25,180,000 | |
| 24,039,000 | |
| 22,634,000 | |
| 22,425,000 | |
| 21,121,000 | |
| 19,872,000 | |
| 18,722,000 | |
| 17,104,000 | |
| 16,516,000 | |
| 16,057,000 | |
| 15,796,000 | |
| 15,545,000 | |
| 15,436,000 | |
| 15,319,000 | |
| 15,180,000 | |
| 14,957,000 | |
| 14,564,000 | |
| 14,038,000 | |
| 13,686,000 | |
| 13,428,000 | |
| 13,252,000 | |
| 13,750,000 | |
| 14,067,000 | |
| 14,285,000 | |
| 14,448,000 | |
| 14,133,000 | |
| 13,723,000 | |
| 13,454,000 | |
| 13,078,000 | |
| 12,552,000 |